How much funding has Faraday Pharmaceuticals raised?

Faraday Pharmaceuticals has raised $99.2M in total funding, most recently a Series B round.

When was Faraday Pharmaceuticals founded?

Faraday Pharmaceuticals was founded in 2016.

Where is Faraday Pharmaceuticals headquartered?

Faraday Pharmaceuticals is headquartered in Seattle, Washington, United States.

What industry is Faraday Pharmaceuticals in?

Faraday Pharmaceuticals operates in Biotech, Healthcare.

How many employees does Faraday Pharmaceuticals have?

Faraday Pharmaceuticals has 11-50 employees.

Faraday Pharmaceuticals

Q: Who are Faraday Pharmaceuticals's investors?

Faraday Pharmaceuticals's investors include ARCH Venture Partners, Polaris Partners, Osage University Partners.

Seattle, United States · Founded 2016 · $99.2M raised

Biotech

Healthcare

Headquarters: Seattle, Washington
Employees: 11–50
Founded: 2016
Business Model: B2B

Website: faradaypharma.com
Total Funding: $99.2M
Last Round: $52.8M Series BNov 2022
Rounds: 5

About

Faraday Pharmaceuticals is a clinical-stage biopharmaceutical company founded by Dr. Mark Roth of the Fred Hutchinson Cancer Center. The company pioneered the use of elemental reducing agents to protect against muscle loss in cardiac and critical care settings. As of 2025, the company has ceased operations and is winding down.

Summary

Faraday Pharmaceuticals is a Biotech company based in Seattle, United States, founded in 2016. It has raised $99.2M in total across 5 rounds, most recently a $52.8M Series B round in Nov 2022. Investors include ARCH Venture Partners, Polaris Partners and Osage University Partners.